Display options
Cite
Ramnani P, Costabile A, Bustillo AG, et al. A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects. J Nutr Sci. 2015;4:e10doi: 10.1017/jns.2014.68.
Ramnani, P., Costabile, A., Bustillo, A. G., & Gibson, G. R. (2015). A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects. Journal of nutritional science, 4e10. https://doi.org/10.1017/jns.2014.68
Ramnani, P, et al. "A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects." Journal of nutritional science vol. 4 (2015): e10. doi: https://doi.org/10.1017/jns.2014.68
Ramnani P, Costabile A, Bustillo AG, Gibson GR. A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects. J Nutr Sci. 2015 Mar 13;4:e10. doi: 10.1017/jns.2014.68. eCollection 2015. PMID: 26090092; PMCID: PMC4463010.
Copy Download .nbib Format: NLM
Share it on

J Nutr Sci. 2015 Mar 13;4:e10. doi: 10.1017/jns.2014.68. eCollection 2015.

A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects.

Journal of nutritional science

P Ramnani, A Costabile, A G R Bustillo, G R Gibson

Affiliations

  1. Department of Food and Nutritional Sciences , University of Reading , Reading RG6 6AP , UK.
  2. Bustar Alimentos , SAPI de CV , Efrain Gonzalez Luna 2503 , Col Arcos Sur, 44130 Guadalajara , Jalisco , Mexico.

PMID: 26090092 PMCID: PMC4463010 DOI: 10.1017/jns.2014.68

Abstract

This placebo-controlled, randomised, double-blind, cross-over human feeding study aimed to determine the prebiotic effect of agave fructans. A total of thirty-eight volunteers completed this trial. The treatment consisted of 3 weeks' supplementation with 5 g/d of prebiotic agave fructan (Predilife) or equivalent placebo (maltodextrin), followed by a 2-week washout period following which subjects were crossed over to alternate the treatment arm for 3 weeks followed by a 2-week washout. Faecal samples were collected at baseline, on the last day of treatment (days 22 and 58) and washout (days 36 and 72), respectively. Changes in faecal bacterial populations, SCFA and secretory IgA were assessed using fluorescent in situ hybridisation, GC and ELISA, respectively. Bowel movements, stool consistencies, abdominal comfort and mood changes were evaluated by a recorded daily questionnaire. In parallel, the effect of agave fructans on different regions of the colon using a three-stage continuous culture simulator was studied. Predilife significantly increased faecal bifidobacteria (log10 9·6 (sd 0·4)) and lactobacilli (log10 7·7 (sd 0·8)) compared with placebo (log10 9·2 (sd 0·4); P = 0·00) (log10 7·4 (sd 0·7); P = 0·000), respectively. No change was observed for other bacterial groups tested, SCFA, secretory IgA, and PGE2 concentrations between the treatment and placebo. Denaturing gradient gel electrophoresis analysis indicated that bacterial communities were randomly dispersed and no significant differences were observed between Predilife and placebo treatments. The in vitro models showed similar increases in bifidobacterial and lactobacilli populations to that observed with the in vivo trial. To conclude, agave fructans are well tolerated in healthy human subjects and increased bifidobacteria and lactobacilli numbers in vitro and in vivo but did not influence other products of fermentation.

Keywords: Agave fructans; DGGE, denaturing gradient gel electrophoresis; FISH, fluorescent in situ hybridisation; Gut microbiota; Prebiotics; SS1, steady state 1; SS2, steady state 2; sIgA, secretory IgA

References

  1. Age (Dordr). 2012 Feb;34(1):133-43 - PubMed
  2. J Immunol. 2013 Sep 15;191(6):3200-9 - PubMed
  3. J Agric Food Chem. 2006 Oct 4;54(20):7832-9 - PubMed
  4. Appl Environ Microbiol. 2000 Oct;66(10):4523-7 - PubMed
  5. Br J Nutr. 2001 Sep;86(3):341-8 - PubMed
  6. J Nutr. 2013 Mar;143(3):324-31 - PubMed
  7. Scand J Gastroenterol Suppl. 1997;222:28-31 - PubMed
  8. Br J Nutr. 2005 Apr;93 Suppl 1:S13-25 - PubMed
  9. Br J Nutr. 1999 Nov;82(5):375-82 - PubMed
  10. Am J Clin Nutr. 2008 Nov;88(5):1438-46 - PubMed
  11. Nutr J. 2012 Jun 01;11:36 - PubMed
  12. J Nutr. 2007 Nov;137(11 Suppl):2503S-2506S - PubMed
  13. J Nutr. 1999 Jul;129(7 Suppl):1412S-7S - PubMed
  14. Br J Nutr. 2012 Aug;108(3):471-81 - PubMed
  15. Appl Environ Microbiol. 1995 Aug;61(8):3069-75 - PubMed
  16. Altern Med Rev. 2009 Mar;14(1):36-55 - PubMed
  17. Syst Appl Microbiol. 1999 Sep;22(3):434-44 - PubMed
  18. Eur J Clin Nutr. 2007 Oct;61(10):1189-95 - PubMed
  19. Eur J Clin Nutr. 2009 Nov;63(11):1277-89 - PubMed
  20. J Agric Food Chem. 2012 Nov 28;60(47):11704-13 - PubMed
  21. Microb Ecol. 1998 Mar;35(2):180-7 - PubMed
  22. J Appl Microbiol. 2010 Jun;108(6):2114-21 - PubMed
  23. Nutr Res Rev. 2000 Dec;13(2):229-54 - PubMed
  24. Br J Nutr. 2010 Oct;104(7):1007-17 - PubMed
  25. Nutr Res Rev. 2004 Jun;17(1):89-98 - PubMed
  26. Appl Environ Microbiol. 2004 Aug;70(8):4505-11 - PubMed
  27. Nutr Rev. 2012 Aug;70 Suppl 1:S10-3 - PubMed
  28. Infect Immun. 1994 Nov;62(11):5191-4 - PubMed
  29. J Appl Microbiol. 2007 Feb;102(2):452-60 - PubMed
  30. Br J Nutr. 2008 Apr;99(4):826-31 - PubMed
  31. Appl Environ Microbiol. 1998 Sep;64(9):3336-45 - PubMed
  32. JPEN J Parenter Enteral Nutr. 1992 Sep-Oct;16(5):433-9 - PubMed
  33. Gastroenterology. 1995 Apr;108(4):975-82 - PubMed
  34. Microbiology. 1996 May;142 ( Pt 5):1097-106 - PubMed
  35. Br J Nutr. 2008 Jan;99(1):110-20 - PubMed
  36. Br J Nutr. 2010 Jul;104(2):233-40 - PubMed
  37. J Agric Food Chem. 2003 Dec 31;51(27):7835-40 - PubMed
  38. Appl Environ Microbiol. 2006 May;72(5):3593-9 - PubMed
  39. Br J Nutr. 2009 Feb;101(3):367-75 - PubMed
  40. Br J Nutr. 2007 Sep;98(3):540-9 - PubMed
  41. Nutrients. 2013 Apr 22;5(4):1417-35 - PubMed
  42. PLoS One. 2013 Oct 24;8(10):e77128 - PubMed
  43. Appl Environ Microbiol. 1993 Mar;59(3):695-700 - PubMed
  44. BMC Gastroenterol. 2007 Sep 04;7:36 - PubMed

Publication Types